Skip to content
OpenCapital
Get started

BioRestorative Therapies BRTX Q3 2025 earnings

Reported November 12, 2025 · After market close

Revenue$11.8KMiss by $448.2K
EPS-$0.33Beat by $0.03
Revenue estimate$460.0K
EPS estimate-$0.36

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$600.0K
EPS estimate-$0.15

Versus estimates

Revenue

Q1 2026$23.2KMiss by $289.3KQ4 2025$20.0KMiss by $130.0K
Q3 2025$11.8KMiss by $448.2K
Q2 2025$303.3KBeat by $103.3KQ1 2025$25.0KMiss by $355.0KQ4 2024$43.3KMiss by $431.7K

Diluted EPS

Q1 2026-$0.19Beat by $0.01Q4 2025-$0.37In line
Q3 2025-$0.33Beat by $0.03
Q2 2025-$0.30Beat by $0.11Q1 2025-$0.56Miss by $0.24Q4 2024-$0.20Beat by $0.07

Ask the moment BioRestorative Therapies reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioRestorative Therapies report Q3 2025 earnings?
BioRestorative Therapies (BRTX) reported Q3 2025 earnings on November 12, 2025 after market close.
What were BioRestorative Therapies's Q3 2025 revenue and EPS?
BioRestorative Therapies reported revenue of $11.8K and eps of $-0.33 for Q3 2025.
Did BioRestorative Therapies beat estimates in Q3 2025?
Revenue missed the consensus estimate of $460.0K by $448.2K. EPS beat the consensus estimate of $-0.36 by $0.03.
How did BioRestorative Therapies's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 94.9% from $233.6K a year earlier and eps declined 153.8% from $-0.13.
Where can I find BioRestorative Therapies's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001021771-25-000148) and the 10-Q periodic report (0001493152-25-021993) directly on SEC EDGAR. The filing index links above go to sec.gov.